morpholinoanthracycline mx2 has been researched along with Vomiting in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuraishi, Y; Ogawa, M; Okabe, K; Sampi, K; Takemoto, Y; Tamura, K | 1 |
| Kuraishi, Y; Ogawa, M; Sampi, K; Takemoto, Y; Tamura, K; Toki, H | 1 |
| Arita, N; Kayama, T; Kubo, N; Kuratsu, JI; Mori, T; Sawamura, Y; Ushio, Y | 1 |
| Majima, H | 1 |
3 trial(s) available for morpholinoanthracycline mx2 and Vomiting
| Article | Year |
|---|---|
[Phase II study of KRN8602 (MX2) for malignant lymphoma].
Topics: Anorexia; Antibiotics, Antineoplastic; Carubicin; Drug Administration Schedule; Hodgkin Disease; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Nausea; Thrombocytopenia; Vomiting | 1998 |
[Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia].
Topics: Adult; Aged; Anorexia; Antibiotics, Antineoplastic; Carubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vomiting | 1998 |
Phase II trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients.
Topics: Adult; Antibiotics, Antineoplastic; Astrocytoma; Brain Neoplasms; Cardiomyopathies; Carubicin; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Glioblastoma; Humans; Leukopenia; Male; Middle Aged; Nausea; Oligodendroglioma; Treatment Outcome; Vomiting | 2000 |
1 other study(ies) available for morpholinoanthracycline mx2 and Vomiting
| Article | Year |
|---|---|
[Phase I clinical study of MX2 (KRN 8602)].
Topics: Adult; Antibiotics, Antineoplastic; Breast Neoplasms; Carubicin; Daunorubicin; Drug Evaluation; Female; Humans; Injections, Intravenous; Leukopenia; Male; Middle Aged; Nausea; Stomach Neoplasms; Vomiting | 1990 |